INTRODUCTION
Many cases of Philadelphia chromosome-positive (Ph-) chronic myelogenous leukemia (CML) have some increase in reticulin fibers in the bone marrow (BM), and some also have increased deposition of collagen, particularly late in the clinical course [1] . Rarely, however, does a patient with Ph ' disease have the clinical and hematologic picture of typical myelofibrosis (MF), as currently defined [2] [3] [4] [5] . We report two such patients and a third Ph" patient with sufficient marrow fibrosis to confuse the initial diagnosis.
CASE REPORTS Case 1 (P.W.)
A 45-year old woman was noted to be anemic; in February 1989 during hospitalization for a herniated disc. Subsequent studies showed a hemoglobin level of 8.8 g/dl, a white blood cell (WBC) count of 8.8 x 109/L, and a platelet count of 987 x 109/L. The peripheral blood (PB) smear showed nucleated red blood cells (RBC), teardrop forms, schistocytes, and a few immature leukocytes. Platelets were increased, with megakaryocyte fragments. A BM biopsy showed marked increase in fibrosis, megakaryocytic hyperplasia, and markedly increased reticulin. The leukocyte alkaline phosphatase (LAP) level was 6 (normal = 27-67). A clinical diagnosis of MF was made. Cytogenetic and molecular genetic: studies were made of the BM at that time.
She was entered on an MF protocol involving treatment blasts. Chromosome studies were made of the BM in January 1990, and the patient was then treated with hydroxyurea, with normalization of her WBC and platelet counts. Since February 1990, she has been participating in a longterm protocol involving treatment with IFN, and her disease has been stable. Repeat chromosome studies were performed in May, August, and November 1990, with molecular studies also perfornted on the latter spe(:imen.
MATERIALS AND METHODS
For chromosome studies, standard G-banded preparations were macie from BM or PB specimens culturect for 24 hours without mitogen [6] .
To determine the involvement of the bcr locus, DNA from cases 1 and 3 was hybridized with both a partial eDNA probe [71 and a genomic probe [Oncogene Science) for the bcr major breakpoint cluster region [8] . For case 2, RNA was extracted from glass slide smears of BM, anct PCR amplification studies for bcr-abl chimeric mRNA were performed, as describect previously [9] . Controls included a known positive CML specimen, vvhich showed evidence of bcr-abl mRNA; appropriate negative controls; and analysis of the patient sample for (:-abl mRNA, which demonstrated that intact mRNA hac| indeed been isolated from the glass slide specimen. Table 1 and Fig. 1 , all BM cells from case 1 had the karyotype 46,XX,t(9;22)(q34;q11),del(20)(q12). The molecular studies showed a single rearranged bcr allele with EcoRl, BamHI, and Bglll enzymes. The pattern suggested that the breakpoint was located in the F2 or F3 region of Sbtalrid [10] , toward the 3' end of the major breakpoint region of typic:al CML.
RESULTS

As indicated in
In case 2, although the c:ytogenetic abnormalities involved the same three (:hromosomes as in case 1, with an apparent Ph chromosome, there was not actually a t{9:22). As indicated in Table 1 and Fig. 2 . the karyotype was interpreted as 46,XX,t[20;22)(p13;q11},del(9)[q34}. All metaphases examined were abnormal, and approximately one third were polyploid, with the same chromosome aberrations. The possibility of a "masked" bcr-abl translocation was (:onsidered, but the PCR amplification studies provided no evidence of b(:r-abl chimeric mRNA.
In case 3, the original (:hromosome study, performed at another institution, demonstrated a Ph chromosome, and our subsequent three studies of BM and PB, summarized in Table 1 , confirmed the karyotype of the neoplastic: (:ells as 46,XX,t(9;22)(q34;q11). All metaphases were abnormal and, as with case 2, a proportion were polyploid, (:onsistent with the observed megakaryocytosis and thrombocytosis. As in case 1, molecular studies for bcr involvement showed a single rearranged bcr allele with both the BamHl and BglIl enzymes. In this case, the pattern indicated that the breakpoint was located in the F1 region, toward the 5' end of the major breakpoint region.
DISCUSSION
These three cases illustrate a variety of ways in which severe marrow fibrosis may be associated with a Ph chromosome. The first case represents the rare circumstance in which the karyotypic abnormalities in a patient with typical MF in(:lude the characteristic t(9;22) usually associated with CML. Only one such case is listed in the 1988 Mitelman catalogue [4] , and a few others have been described in earlier articles [2, 3] . None have been previously studied for b(:r rearrangement. The fibrous proliferation in MF is not part of the preneoplastic or neoplastic (:lone, but is apparently stimulated by products of the abnormal heroic cells, particularly platelet-derived growth factor (PDGF) [5, 11, 12] . This helps to explain the coexisten(:e of megakaryo(:ytosis and marrow fibrosis in this (:as(;, as well as in (:ase 3, although it is not known what genetic alteration, if any, in the neoplastic: cells, other than the bcr-abl transh)cation contributes to this phenomenon. In case 1, the del(20q) abnormality may have contributed to the spe-(:ific phenotype, ttowever, although this alteration does occur nonrandomly in MF, it has also been associated with a variety of other myeloproliferative and mvelodysplastic disorders [4, 5, [13] [14] [15] [16] , as well as with some cases (if Ph' CML without significant MF [17, 18] . There has been recent spe(:ulation that this del [20) (q13) abnormality might spe(:ifically involve the hck gene (C. Willman, personal communication), whi(:h maps to this region and codes for a tyr()sine kinase, but this has not been confirmed, and in this t)articular case no rearrangement of the hck gene was detected on standard Southern blots {K. l luebner, personal communication). The second case was also considered typical MF when studied clini(:ally and hematologically at a number of medical centers in the United States and the United King- ~J .'". dil 16 17 18 "-
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Representative karyotype from marrow of patient 1 (P.W.): 46,XX,t(9;22)(q34:q11),c|el (20)(q12).
dom. The karyotype also appeared initially to contain a Ph chromosome. However, both cytogenetic and molecular analysis indicated that there was not a bc:r-abl translocation, but instead an unusual t(20:22)(p13;qll), as well as a small deletion from the terminal portion of the long arm of one chromosome 9. The t(20;22) has not previously been described in myeloproliferative or myelodysplastic disorders, but there have been at least two reported cases of Ph ~ CML with translocations involving the short arm of chromosome 20, although neither was confirmed at the molecular level as having a bcr rearrangement. In one instance, the translocation was described as t(9;20;22)(q34;p11-13;q11) [19] , and in the other as'simply t(20;22)(p12;q11) [20] . Because of the overall rarity in hemic disorders of these rearrangements involving 20p, speculating about their significance is difficult. Figure 2 Representative karyotype froln marrow of patient 2 (S.S.): 46,XY,t(20:22)(p13;qlll,del(9)(q34). The third case exemplifies a somewhat more common entity in the spectrum of disorders that range from typical CML with minor degrees of marrow fibrosis and/or megakaryocytosis to Ph * cases initially appearing as typical essential thrombocythemia (ET) with marked increase in megakaryocytes and platelets anti with some degree of marrow fibrosis [21, 22] . This particular case was unusual in that the severity of the fibrosis complicated the original diagnosis, raising a question of whether the patient should be considered, and managed, as having MF or CML. These three cases indicate the need for careful evaluation, including appropriate cytogenetic and molecular studies, of all patients who initially have severe marrow fibrosis, as treatment options are considered.
